|
|
42
|
|
|
B4218
|
|
|
FORXIGA 5MG TAB (AZN) DAPAGLIFLOZIN
|
|
|
DAPAGLIFLOZIN
|
|
|
FORXIGA
|
|
|
30'S
|
|
|
C
|
|
|
61.60
|
|
|
2.05
|
|
|
5MG
|
|
|
TAB
|
|
|
30
|
|
|
BLIS
|
|
|
AZN
|
|
|
ASTRAZENECA AB
|
|
|
COL
|
|
|
AVENTA BARBADOS
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
682018
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|